• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下腔静脉先天性畸形和杂合子因子 V Leiden 导致的深静脉血栓形成,表现为静脉跛行。

Deep venous thrombosis caused by congenital malformation of the inferior vena cava and heterozygous factor V leiden presenting as venous claudication.

机构信息

Department of Emergency, Brugmann University Hospital, Brussels, Belgium.

出版信息

Clin Appl Thromb Hemost. 2009 Oct;15(5):591-5. doi: 10.1177/1076029608324928. Epub 2008 Nov 2.

DOI:10.1177/1076029608324928
PMID:18980946
Abstract

A case of an 18-year-old man with deep venous thrombosis of the lower limbs caused by hypoplasia of the inferior vena cava in combination with heterozygous factor V Leiden is presented. Both anomalies were found when the patient complained of venous claudication in both thighs. Inferior vena cava malformation is a rare condition and may predispose to the development of deep venous thrombosis. This patient was at an even higher risk for deep venous thrombosis as the inferior vena cava malformation was combined with a hypercoagulable state.

摘要

现报告 1 例 18 岁男性患者,因下腔静脉发育不良合并杂合子因子 V 莱顿突变导致下肢深静脉血栓形成。患者出现双大腿静脉跛行时发现了这两种异常。下腔静脉畸形是一种罕见的疾病,可能易导致深静脉血栓形成。由于下腔静脉畸形合并高凝状态,该患者发生深静脉血栓形成的风险更高。

相似文献

1
Deep venous thrombosis caused by congenital malformation of the inferior vena cava and heterozygous factor V leiden presenting as venous claudication.下腔静脉先天性畸形和杂合子因子 V Leiden 导致的深静脉血栓形成,表现为静脉跛行。
Clin Appl Thromb Hemost. 2009 Oct;15(5):591-5. doi: 10.1177/1076029608324928. Epub 2008 Nov 2.
2
[Agenesis of inferior vena cava combined with multiple genetic predisposition in the case of deep venous thrombosis in a young male].一名年轻男性深静脉血栓形成病例中,下腔静脉缺如合并多种遗传易感性
Orv Hetil. 2003 Nov 16;144(46):2283-6.
3
[A case report of posttraumatic deep vein thrombosis of the lower limbs in a patient with factor V Leiden mutation and the congenital absence of the inferior vena cava].[一例伴有凝血因子V莱顿突变及先天性下腔静脉缺如患者的创伤后下肢深静脉血栓形成病例报告]
Pol Arch Med Wewn. 2006 Apr;115(4):345-50.
4
Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis.下腔静脉先天性异常与易导致深静脉血栓形成的凝血因子V莱顿突变
Vasc Health Risk Manag. 2014 Nov 4;10:609-13. doi: 10.2147/VHRM.S66283. eCollection 2014.
5
Recurrent deep venous thrombosis caused by congenital interruption of the inferior vena cava and heterozygous factor V Leiden mutation.先天性下腔静脉中断和杂合子因子V莱顿突变引起的复发性深静脉血栓形成。
J Intern Med. 2002 Sep;252(3):276-80. doi: 10.1046/j.1365-2796.2002.01034.x.
6
[Vena cava inferior atresia as the cause of deep venous thrombosis].[下腔静脉闭锁作为深静脉血栓形成的原因]
Ugeskr Laeger. 2003 Apr 28;165(18):1880-1.
7
Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young.下腔静脉畸形作为年轻人深静脉血栓形成的一个危险因素。
Br J Haematol. 2001 Sep;114(4):878-80. doi: 10.1046/j.1365-2141.2001.03025.x.
8
Inferior vena cava agenesia and a massive bilateral iliofemoral venous thrombosis.下腔静脉发育不全及巨大双侧髂股静脉血栓形成。
Angiology. 2008 Aug-Sep;59(4):510-3. doi: 10.1177/0003319707305350. Epub 2008 Apr 2.
9
Bilateral Deep Vein Thrombosis Associated with Inferior Vena Cava Agenesis in a Young Patient Manifesting as Low Back Pain.一名年轻患者表现为腰痛,双侧深静脉血栓形成与下腔静脉发育不全相关。
Acta Med Port. 2017 Apr 28;30(4):333-337. doi: 10.20344/amp.7744.
10
Massive deep venous thrombosis, congenital interruption of the inferior vena cava and heterozygosity for factor V Leiden.
Thromb Haemost. 2000 Dec;84(6):1121-2.

引用本文的文献

1
Lower extremity venous thrombosis in patients younger than 50 years of age.50岁以下患者的下肢静脉血栓形成
Vasc Health Risk Manag. 2012;8:161-7. doi: 10.2147/VHRM.S29457. Epub 2012 Mar 13.
2
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?在黎巴嫩患者中,血栓形成倾向是下肢深静脉血栓形成的主要危险因素吗?
Vasc Health Risk Manag. 2009;5:627-33. doi: 10.2147/vhrm.s6184. Epub 2009 Aug 6.